Evidence map›Paper›PMID 28153007›Full record

ArticleBMC musculoskeletal disorders2017

Musculoskeletal disorders as underlying cause of death in 58 countries, 1986-2011: trend analysis of WHO mortality database.

Aliasghar A Kiadaliri, Anthony D Woolf, Martin Englund

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Innovation in Orthopedics: Part 1-Design Thinking.Current reviews in musculoskeletal medicine · 2022
    Review
  4. Article
  5. Rheumatology in Ukraine.Rheumatology international · 2020
    Review
  6. Article
  7. What is the current evidence of the impact on quality of life whilst waiting for management/treatment of orthopaedic/musculoskeletal complaints? A systematic scoping review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Aliasghar A KiadaliriDepartment of Clinical Sciences Lund, Lund University, Faculty of Medicine, Orthopaedics, Skåne University Hospital, Clinical Epidemiology Unit, Klinikgatan 22, SE-221 85, Lund, Sweden. aliasghar.ahmad_kiadaliri@med.lu.se.
Anthony D WoolfBone and Joint Research Group, The Knowledge Spa, Royal Cornwall Hospital, Truro, UK.
Martin EnglundDepartment of Clinical Sciences Lund, Lund University, Faculty of Medicine, Orthopaedics, Skåne University Hospital, Clinical Epidemiology Unit, Klinikgatan 22, SE-221 85, Lund, Sweden.
Skåne University Hospital · SERoyal Cornwall Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to low mortality rate of musculoskeletal disorders (MSK) less attention has been paid to MSK as underlying cause of death in the general population. The aim was to examine trend in MSK as underlying cause of death in 58 countries across globe during 1986-2011.

methodsData on mortality were collected from the WHO mortality database and population data were obtained from the United Nations. Annual sex-specific age-standardized mortality rates (ASMR) were calculated by means of direct standardization using the WHO world standard population. We applied joinpoint regression analysis for trend analysis. Between-country disparities were examined using between-country variance and Gini coefficient. The changes in number of MSK deaths between 1986 and 2011 were decomposed using two counterfactual scenarios.

resultsThe number of MSK deaths increased by 67% between 1986 and 2011 mainly due to population aging. The mean ASMR changed from 17.2 and 26.6 per million in 1986 to 18.1 and 25.1 in 2011 among men and women, respectively (median: 7.3% increase in men and 9.0% reduction in women). Declines in ASMR of 25% or more were observed for men (women) in 13 (19) countries, while corresponding increases were seen for men (women) in 25 (14) countries. In both sexes, ASMR declined during 1986-1997, then increased during 1997-2001 and again declined over 2001-2011. Despite decline over time, there were substantial between-country disparities in MSK mortality and its temporal trend.

conclusionsWe found substantial variations in MSK mortality and its trends between countries, regions and also between sex and age groups. Promoted awareness and better management of MSK might partly explain reduction in MSK mortality, but variations across countries warrant further investigations.

Indexed as

Health Status DisparitiesAdolescentAdultAgedAge FactorsCause of DeathChildChild, PreschoolDatabases, FactualFemaleHumansInfantInfant, NewbornMaleMusculoskeletal DiseasesRegression Analysis

Identifiers

PMID28153007
PMCPMC5290674
OpenAlexW2585856210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.